BRYN KRAUSE: Open Payments
NPI 1164875852 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,336 in 184 payments from 21 companies in 2025. Trend: 2023 $1,720 · 2024 $2,264 · 2025 $4,336
Food & beverage: $4,124Education: $212
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 42 | $1,040 |
| ABBVIE INC. | 40 | $595 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $354 |
| Novartis Pharmaceuticals Corporation | 11 | $347 |
| UCB, Inc. | 8 | $346 |
| GENZYME CORPORATION | 9 | $307 |
| Arcutis Biotherapeutics, Inc. | 13 | $210 |
| PFIZER INC. | 16 | $206 |
| Lilly USA, LLC | 5 | $181 |
| Regeneron Healthcare Solutions, Inc. | 6 | $165 |
Products named: TREMFYA, DUPIXENT, Bimzelx, RINVOQ, ILUMYA, SKYRIZI, Zoryve, CIBINQO.
Industry payments across IL — which companies pay providers there.
